N-methylnicotinamide

DB08840InvestigationalSmall molecule

N-methylnicotinamide is an experimental drug with no approved indication or marketed formulation. It is a metabolite of niacinamide/nicotinamide and niacin/nicotinic acid (vitamin B3), and as such N-methylnicotinamide is used to...

Chemical structure of N-methylnicotinamide
Primary indication
N-methylnicotinamide is an experimental drug with no approved indication.Curator reviewed
Formula / weight
C7H8N2O · 136.1512 g/mol (avg)
Also known as
Nicotinic acid methylamide · Nicotinyl methylamide
Code names
NSC-66521 · SR-4415

Resolves to

Compound
UNIIX3I82S5L8ICAS114-33-0ChEMBLCHEMBL11978ChEBI64399
Clinical / RWD
ATCA05AB01
Structure
InChIKeyZYVXHFWBYUDDBM-UHFFFAOYSA-NSMILESCNC(=O)C1=CC=CN=C1
Targets
P29597TYK2
Transporters
O15244SLC22A2Q96FL8SLC47A1Q86VL8SLC47A2

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
762Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 10 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with N-methylnicotinamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In